US Patent 11352356 Inhibitors of plasma kallikrein and uses thereof
Patent 11352356 was granted and assigned to Takeda Pharmaceutical Company on June, 2022 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11352356 Inhibitors of plasma kallikrein and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
